Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,916
Total Claims
$1.2M
Drug Cost
883
Beneficiaries
$1,337
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-36%
Opioid rate vs peers
1.7% vs 2.6% avg
+25%
Cost per patient vs peers
$1,337 vs $1,068 avg
+9%
Brand preference vs peers
9.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.7%
Opioid Rate
197
Opioid Claims
$12K
Opioid Cost
11.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,146 claims · $916K
Generic: 10,589 claims · $245K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 106 | $163K |
| Apixaban | 75 | $87K |
| Dulaglutide | 37 | $68K |
| Fluticasone/Umeclidin/Vilanter | 47 | $33K |
| Semaglutide | 34 | $32K |
| Mirabegron | 37 | $30K |
| Empagliflozin/Metformin Hcl | 18 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 35 | $30K |
| Sitagliptin Phosphate | 17 | $25K |
| Sitagliptin Phos/Metformin Hcl | 21 | $25K |
| Fluticasone/Vilanterol | 52 | $24K |
| Rivaroxaban | 19 | $17K |
| Insulin Aspart Prot/Insuln Asp | 12 | $17K |
| Irbesartan | 415 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $14K |
Prescribing Profile
Patient Profile
73
Avg Age
52%
Female
1.03
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data